Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction

Diagnostic Molecular Pathology

Volumn 8, Issue 2, 1999, Pages 59-65

  Ghossein, Ronald A ^a   Osman, Iman ^a   Bhattacharya, Satyajit ^a   Ferrara, Jay ^a   Fazzari, Melissa ^a   Cordon Cardo, Carlos ^a   Scher, Howard I ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Immunobead; Prostatic carcinoma; Prostatic specific membrane antigen; Reverse transcriptase polymerase chain reaction

Indexed keywords

ANTIBODY; EPITHELIAL MEMBRANE ANTIGEN; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; THYMIDINE DERIVATIVE;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CARCINOMA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; GENE ISOLATION; HUMAN; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ANTIGENS, SURFACE; BLOTTING, SOUTHERN; CARBOXYPEPTIDASES; ELECTROPHORESIS, AGAR GEL; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; IMMUNOMAGNETIC SEPARATION; MALE; NEOPLASM CIRCULATING CELLS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032795596     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199906000-00001     Document Type: Article

References (25)

1. Ben-Ezra J, Johnson DA, Rossi J, Cook N, Wu A. Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. J Histochem Cytochem 1991;39:351-4.
2. Cama C, Olsson CA, Buttyan R, de Vries GM, Wise GJ, Katz AE. Molecular staging of prostatic cancer.III. Effects of cystoscopy and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay. J Urol 1997;157:1748-51.
3. Ellis WJ, Vessella RL, Corey E, Arfman EW, Oswin MM, Melchior S, Lange PH. The value of reverse transcriptase polymerase chain reaction assay in preoperative staging and follow up of patients with prostate cancer. J Urol 1998;159:1134-8.
4. Gaffey MJ, Mills SE, Swanson PE, Zarbo RJ, Shah AR, Wick MR. Immunoreactivity for Ber-EP4 in adenocarcinomas, adenomatoid tumor and malignant mesotheliomas. Am J Surg Pathol 1992;16: 714-21.
5. Ghossein R, Scher HI, Gerald W, et al. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: Clinical implications. J Clin Oncol 1996;13:1195-2000.
6. Gregorakis AK, Holmes EH, Murphy GP. Prostate-specific membrane antigen: current and future utility. Semin Urol Oncol 1998; 16:2-12.
7. Hardingham JE, Kotasek D, Farmer B, Butler RN, Jing-Xian Mi, Sage RE, Dobrovic A. Immunobead-PCR: A technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res 1993;53:3455-8.
8. Israeli RS, Miller WH, Su SL, et al. Sensitive nested reverse transcriptase polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen based assays. Cancer Res 1994; 54:6306-10.
9. Johnson PWM, Burchill SA, Selby PJ. The molecular detection of circulating tumor cells. Br J Cancer 1995;72:268-76.
10. Kaplan JC, Kahn A, Chelly J. Illegitimate transcription: its study in the use of inherited disease. Hum Mutat 1992;1:357-60.
11. Katz AE, Devries GM, Begg MD, et al. Enhanced reverse transcriptase-polymerase chain reaction for prostatic specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer 1995;75:1642-8.
12. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 1990;43:213-9.
13. Makarovskiy AN, Ackerly III W, Wojcik L, Halpert GK, Stein BS, Carreiro MP, Hixson DC. Application of immunomagnetic beads in combination with RT PCR for the detection of circulating prostate cancer cells. J Clin Lab Anal 1997;11:346-50.
14. Mattano LA, Moss TJ, Emerson SJ. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 1992;52:4701-5.
15. Moreno JG, Croce CM, Fischer R, Monne M, Vikho P, Mulholland SG, Gomella LG. Detection of hematogenous micrometastases in patients with prostate cancer. Cancer Res 1992;52:6110-2.
16. Naume B, Borgen E, Beiske K, et al. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hemathother 1997;6:103-14.
17. Oefelein MG, Kaul K, Herz B, et al. Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J Urol 1996;155:238-42.
18. Oesterling JF, Rice DC, Glenski WJ, Bergstralh EJ. Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology 1993;42: 276-82.
19. Olsson CA, de Vries GM, Buttyan R, Katz AE. Reverse transcriptase-polymerase chain reaction assays for prostate cancer. Urol Clin North Am 1997;24:367-78.
20. Price DK, Woodard WL, Teigland CM. Simultaneous detection of prostate specific-antigen-expressing and prostate specific membrane antigen-expressing cells by a multiplex reverse transcriptase polymerase chain reaction assay. Urol Oncol 1995;1:226-33.
21. Scher HI, Mazumdar M, Kelly WK. Clinical trials in relapsed prostate cancer: defining the target. J Natl Cancer Inst 1996;88: 1623-34.
22. Schroeder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone Macaluso M. The TNM classification of prostatic cancer. Prostate 1992;4(suppl):129-38.
23. Seiden MV, Kantoff PW, Krithivas K, et al. Detection of circulating tumor cells in men with localized prostatic cancer. J Clin Oncol 1994;12:2634-9.
24. Smith MR, Biggar S, Hussain M. Prostate specific antigen messenger RNA is expressed in non-prostate cells: Implications for detection of micrometastases. Cancer Res 1995;55:2640-4.
25. Sokoloff MH, Tso CL, Kaboo R, et al. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: A clinicopathologic molecular analysis of 121 patients. J Urol 1996;156:1560-6.